These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25514036)

  • 41. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectin.
    Krumbholz G; Junker S; Meier FMP; Rickert M; Steinmeyer J; Rehart S; Lange U; Frommer KW; Schett G; Müller-Ladner U; Neumann E
    Clin Exp Rheumatol; 2017; 35(3):406-414. PubMed ID: 28079506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
    Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
    Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Th17 cells and rheumatoid arthritis--from the standpoint of osteoclast differentiation--.
    Sato K
    Allergol Int; 2008 Jun; 57(2):109-14. PubMed ID: 18427163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system.
    De Benedetti F; Rucci N; Del Fattore A; Peruzzi B; Paro R; Longo M; Vivarelli M; Muratori F; Berni S; Ballanti P; Ferrari S; Teti A
    Arthritis Rheum; 2006 Nov; 54(11):3551-63. PubMed ID: 17075861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
    Baum R; Gravallese EM
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteoblast lineage-specific cell-surface antigen (A7) regulates osteoclast recruitment and calcification during bone remodeling.
    Badawy T; Kyumoto-Nakamura Y; Uehara N; Zhang J; Sonoda S; Hiura H; Yamaza T; Kukita A; Kukita T
    Lab Invest; 2019 Jun; 99(6):866-884. PubMed ID: 30742099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nrf2 activation in osteoblasts suppresses osteoclastogenesis via inhibiting IL-6 expression.
    Narimiya T; Kanzaki H; Yamaguchi Y; Wada S; Katsumata Y; Tanaka K; Tomonari H
    Bone Rep; 2019 Dec; 11():100228. PubMed ID: 31763378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention.
    Karmakar S; Kay J; Gravallese EM
    Rheum Dis Clin North Am; 2010 May; 36(2):385-404. PubMed ID: 20510240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Depletion of Intestinal Microbiome Partially Rescues Bone Loss in Sickle Cell Disease Male Mice.
    Tavakoli S; Xiao L
    Sci Rep; 2019 Jun; 9(1):8659. PubMed ID: 31209247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene.
    Shukla P; Mansoori MN; Kakaji M; Shukla M; Gupta SK; Singh D
    J Biol Chem; 2017 Mar; 292(11):4686-4699. PubMed ID: 28130449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Regulation of bone by IL-17-producing T cells].
    Okamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(5):361-366. PubMed ID: 29238018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling.
    Razawy W; van Driel M; Lubberts E
    Eur J Immunol; 2018 Feb; 48(2):220-229. PubMed ID: 29148561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo.
    Chang MK; Raggatt LJ; Alexander KA; Kuliwaba JS; Fazzalari NL; Schroder K; Maylin ER; Ripoll VM; Hume DA; Pettit AR
    J Immunol; 2008 Jul; 181(2):1232-44. PubMed ID: 18606677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anti-RANKL antibody for the treatment of bone and cartilage destruction in rheumatoid arthritis].
    Nakayamada S; Tanaka Y
    Clin Calcium; 2015 Dec; 25(12):1787-93. PubMed ID: 26608853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteoimmunology: Influence of the Immune System on Bone Regeneration and Consumption.
    Limmer A; Wirtz DC
    Z Orthop Unfall; 2017 Jun; 155(3):273-280. PubMed ID: 28683495
    [No Abstract]   [Full Text] [Related]  

  • 58. Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications.
    Shim JH; Stavre Z; Gravallese EM
    Calcif Tissue Int; 2018 May; 102(5):533-546. PubMed ID: 29204672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL15RA is required for osteoblast function and bone mineralization.
    Loro E; Ramaswamy G; Chandra A; Tseng WJ; Mishra MK; Shore EM; Khurana TS
    Bone; 2017 Oct; 103():20-30. PubMed ID: 28602725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-35 prevent bone loss through promotion of bone formation and angiogenesis in rheumatoid arthritis.
    Liu S; Li Y; Xia L; Shen H; Lu J
    Clin Exp Rheumatol; 2019; 37(5):820-825. PubMed ID: 30767867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.